BridgeMD
New treatment option for Acute Coronary Syndrome
Official title Cholesterol Self-testing in Patients Post Acute Coronary Syndrome
ClinicalTrials.gov ID: NCT06526013
What this study is testing
- What it's testing
- The pharmacological reduction of LDL-C lowers cardiovascular risk and is therefore a priority in cardiovascular secondary prevention. The achievement of LDL-C target levels in Germany, Europe, and worldwide is inadequate, despite a wide array of lipid-lowering medications.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years
- Patients with acute coronary syndrome in the last 6 months and not having reached the LDL target value
- Signed informed consent
You likely can't join if
- Persons unable to understand the study
- Persons unable or unwilling to perform self-measurements
- Persons unable or unwilling to undergo additional cholesterol-lowering therapy to reach the LDL target
- Pre-menopausal women without contraception
- Use of experimental drugs or investigational products within 30 days prior to screening
- Employees or contractors of the institution conducting the study or family members of the Principal Investigator, Co-Investigator, or financial...
The study team makes the final eligibility decision.
Where it's taking place
- Leipzig, Saxony, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Leipzig, Saxony, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.